Abstract
Gastric cancer is the third leading cause of cancer death worldwide, besides the reduction in its incidence. Late diagnosis usually occurs due to the absence of symptoms or the presence of non-specific symptoms in early stages of the disease. In this case, the available therapeutic options are not efficient, resulting in high morbidity and mortality rates. The continuous study of new stra…